Ying Tang

机构：Soochow University, Affiliated Hospital of North Sichuan Medical College · ORCID：0000-0001-9318-8986

发表论文 54 篇 · 总被引 290 次 · h-index 9

代表论文

• Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China (2024 · The Lancet · 被引 112)
• Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer (2020 · Journal of Cancer · 被引 25)
• Serum CA125 as a biomarker for dysmenorrhea in adenomyosis (2023 · International Journal of Gynecology & Obstetrics · 被引 24)
• Preoperative CA125 as a risk factor for symptom recurrence of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery (2022 · International Journal of Hyperthermia · 被引 17)
• Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer (2021 · Journal of Cancer · 被引 16)
• Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study (2018 · Kidney & Blood Pressure Research · 被引 11)